Be aware that it is a net number. Having seen other such trailing commissions structures for drugs the internal ongoing costs the company puts on th edrug are astonishing ( marketing , junkets the full works and % of corporate costs etc etc) and until those ongoing costs Nadda comes home and then all the development costs are paid backso nothing flows for quite a period IMO. We will never see the fine print. .
Generic competition at much lower price changes market bit other side is a better drug regimine in patent will command a high price if it has signifiicant inprovement in dosage , effectiveness or side affects . Uptake and insurance companies can be slow as well or fast if it is ecconomically better.
- Forums
- ASX - By Stock
- SPL
- Double or Triple?
Double or Triple?, page-24
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20455 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 38876 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20455 | 0.097 |
1 | 100000 | 0.096 |
2 | 60526 | 0.095 |
1 | 10000 | 0.094 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 38876 | 3 |
0.105 | 199768 | 2 |
0.110 | 226808 | 10 |
0.115 | 85453 | 2 |
0.120 | 79405 | 9 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |